Abstract:CCAAT enhancer binding protein-alpha (C/EBP-alpha) is a transcript factor that regulates adipocyte differentiation and induces apoptosis in hepatic stellate cells (HSCs) in vivo and in vitro. However, the effect of C/EBP-alpha on hepatocytes in vivo remains unknown. This study investigated whether C/EBP-alpha exerts different apoptotic effects on hepatocytes and HSCs in vitro and in vivo. An adenovirus vector-expressing C/EBP-alpha gene was constructed, and a rat hepatic stellate cell lines (HSC-T6) and hepatocytes were transfected. A CCl4-induced liver fibrosis model in mice was also utilized. C/EBP-alpha induced apoptosis in hepatocytes and HSCs, but a significant difference between these cell types was observed in vitro. The mitochondrial pathway was involved in the apoptotic process and was predominant in HSC-T6 apoptosis. In the CCl4-induced mice liver fibrosis model, the administration of Ad-C/EBP-alpha decreased extracellular matrix deposition, including collagen and hydroxyproline content, and gamma-GT levels, a marker of liver damage, were reduced significantly. Immunohistochemistry and TUNEL assay results showed an increase of apoptosis in HSCs, but hepatocytes were less affected. C/EBP-alpha induced differential apoptotic effects in hepatocytes and HSCs in vitro and in vivo. This differential effect could be a potential target for the treatment of hepatic fibrosis with little hepatic toxicity.

C/Ebp-Alpha Ameliorates Ccl4-Induced Liver Fibrosis In Mice Through Promoting Apoptosis Of Hepatic Stellate Cells With Little Apoptotic Effect On Hepatocytes In Vitro And In Vivo